BPC-157, a stable gastric pentadecapeptide, demonstrates broader systemic healing effects across multiple tissue types including tendons, muscles, and the gastrointestinal tract through angiogenic and growth factor pathways
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy: BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling positive-like symptoms of schizophrenia
Allow minimum eight weeks at any concentration before considering increases
It initiates a wave of electrical silence called Cortical Spreading Depression (CSD)
Timing, Duration, and Protocol Design Copper peptide dosing timing is more flexible than for growth hormone secretagogues, because GHK-Cu does not have the strict empty-stomach and circadian-alignment requirements of GH-axis peptides
B-6 or B-12 for Anxiety